The Fort Worth Press - Boomerang Ventures Leads Strategic Investment in IMPOWER HEALTH, Appoints Trent McCracken as CEO

USD -
AED 3.673008
AFN 64.503214
ALL 80.819685
AMD 361.405228
ANG 1.789785
AOA 917.000132
ARS 1525.743205
AUD 1.42204
AWG 1.80125
AZN 1.694926
BAM 1.741787
BBD 2.015015
BDT 123.745402
BGN 1.747831
BHD 0.377604
BIF 3000.997453
BMD 1
BND 1.278059
BOB 11.730759
BRL 5.0336
BSD 1.000472
BTN 94.559477
BWP 13.70595
BYN 2.971479
BYR 19600
BZD 2.012094
CAD 1.40468
CDF 2315.999614
CHF 0.823985
CLF 0.02484
CLP 977.639757
CNY 6.67805
CNH 6.673855
COP 3194.48
CRC 455.529135
CUC 1
CUP 24.010794
CVE 98.199695
CZK 21.58565
DJF 177.720049
DKK 6.651515
DOP 61.440772
DZD 134.600855
EGP 54.383604
ERN 15
ETB 163.87083
EUR 0.88984
FJD 2.253797
FKP 0.747587
GBP 0.74635
GEL 2.589651
GGP 0.747587
GHS 11.660299
GIP 0.747587
GMD 73.49688
GNF 8854.987666
GTQ 7.645587
GYD 209.311853
HKD 7.846885
HNL 26.857072
HRK 6.703799
HTG 131.084908
HUF 325.065498
IDR 18027.05
ILS 3.088402
IMP 0.747587
INR 94.43255
IQD 1516.6493
IRR 1832374.999738
ISK 121.269746
JEP 0.747587
JMD 158.780625
JOD 0.709015
JPY 158.134988
KES 129.859579
KGS 87.449845
KHR 4068.146802
KMF 439.503571
KPW 899.999961
KRW 1325.979763
KWD 0.31018
KYD 0.833753
KZT 446.890557
LAK 22518.390538
LBP 89591.044298
LKR 332.14739
LRD 170.580744
LSL 16.412051
LTL 2.95274
LVL 0.60489
LYD 6.419294
MAD 9.819615
MDL 17.998442
MGA 4521.489767
MKD 54.903951
MMK 2099.21541
MNT 3597.533576
MOP 8.085932
MRU 40.128421
MUR 47.319959
MVR 15.459751
MWK 1734.751129
MXN 18.645615
MYR 4.081198
MZN 63.902977
NAD 16.412051
NGN 1331.830194
NIO 36.816372
NOK 9.371645
NPR 151.295341
NZD 1.75332
OMR 0.384501
PAB 1.000481
PEN 3.438421
PGK 4.479652
PHP 63.399499
PKR 276.89823
PLN 3.87625
PYG 5756.677086
QAR 3.647261
RON 4.753003
RSD 104.53802
RUB 82.104013
RWF 1478.615162
SAR 3.748965
SBD 8.07458
SCR 13.97401
SDG 601.492558
SEK 9.878845
SGD 1.27707
SHP 0.7473
SLE 23.919966
SLL 20969.504398
SOS 571.749178
SRD 37.735499
STD 20697.981008
STN 21.819089
SVC 8.754392
SYP 13001.999685
SZL 16.418788
THB 33.570497
TJS 9.214157
TMT 3.51
TND 2.986543
TOP 2.40776
TRY 49.598465
TTD 6.792416
TWD 32.411301
TZS 2644.999678
UAH 45.047334
UGX 4207.076509
UYU 40.164934
UZS 11975.562621
VES 879.788897
VND 25856.5
VUV 119.136032
WST 2.774679
XAF 583.696876
XAG 0.017313
XAU 0.000241628771
XCD 2.70255
XCG 1.803058
XDR 0.707052
XOF 583.696876
XPF 106.20998
YER 236.101147
ZAR 16.360597
ZMK 9001.202969
ZMW 20.069287
ZWL 321.999592
SSP 5787.554334
MXV 2.10465
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Boomerang Ventures Leads Strategic Investment in IMPOWER HEALTH, Appoints Trent McCracken as CEO
Boomerang Ventures Leads Strategic Investment in IMPOWER HEALTH, Appoints Trent McCracken as CEO

Boomerang Ventures Leads Strategic Investment in IMPOWER HEALTH, Appoints Trent McCracken as CEO

Standardizing the 6th Vital Sign: Bringing Lab-grade Mobility Diagnostics to Everyday Clinics

Text size:

INDIANAPOLIS, IN / ACCESS Newswire / February 17, 2026 / Boomerang Ventures, a leading digital health tech-focused venture studio and fund, leads the pre-seed round for IMPOWER HEALTH, a first-of-its-kind health-tech company redefining how mobility is measured, managed, and improved. With this investment, IMPOWER HEALTH joins the Boomerang Ventures portfolio and appoints healthcare and technology executive Trent McCracken as Chief Executive Officer.

IMPOWER HEALTH leverages patented software to capture clinically meaningful gait metrics without wearables, cameras, or workflow disruption. The platform enables objective, reimbursable mobility insights across rehabilitation, performance, and preventive health settings.

"Impower Health represents exactly the type of category-defining innovation we look to support. Their technology sits at the intersection of rehab, fitness, and long-term mobility health, turning everyday treadmills into clinical-grade diagnostic tools," said Eric Beier, MD, Partner & Chief Medical Officer of Boomerang Ventures. "With Trent McCracken stepping in as CEO, Impower has the leadership in place to translate this convergence into scalable impact."

From Cardio Equipment to Clinical Intelligence

IMPOWER HEALTH is setting a new global standard in movement health through a high-precision diagnostic platform. By enabling treadmills to generate high-quality, lab-grade gait data, IMPOWER HEALTH replaces subjective observation with objective, data-driven clinical intelligence, accelerating recovery, optimizing fitness, and helping prevent the loss of mobility and independence.

The company's technology supports a continuum of care, from post-acute rehabilitation to performance optimization, while laying the groundwork for a library of gait biomarkers that enable the detection and prevention of mobility decline long before it begins.

A Market Ripe for Disruption

IMPOWER HEALTH is entering a rapidly expanding mobility health and rehabilitation technology market, driven by aging demographics, rising musculoskeletal disorders, and growing demand for quantifiable, reimbursable functional assessments. In the U.S. alone, an estimated 26,000 outpatient rehab clinics and 10,000 mid-to-premium fitness facilities operate approximately 230,000 treadmills across clinical and commercial settings, according to research.

By turning the world's most common piece of exercise equipment into a high-precision diagnostic tool, IMPOWER HEALTH is moving mobility health from a subjective 'wait and see' model to an objective 'track and treat' reality. This allows clinicians to validate progress with reimbursable data, while active patients gain the real-time feedback needed to identify 'silent' mobility decline before it leads to injury or loss of independence.

"Boomerang Ventures has provided the environment necessary to move beyond simple acceleration into deep market de-risking," said Trent McCracken, CEO of IMPOWER HEALTH. "Their engagement has been instrumental in pressure-testing our commercialization strategy and refining our IP strategy for long-term OEM licensing. This operational partnership has allowed us to enter 2026 with a highly credible, execution-ready foundation."

Leadership Driving the Next Chapter

As CEO, McCracken will guide IMPOWER HEALTH through commercialization, strategic partnerships, and capital formation.

"One of the most compelling aspects of Impower Health is the opportunity to make a tangible difference in people's lives by restoring and preserving mobility, a core component of health and independence. The healthcare market is demanding integrated, data-driven solutions, and we are uniquely positioned to accelerate growth and convert these gait metrics into clinical intelligence," added McCracken.

Founded in 2021 by Doug Miller, a biomedical engineer and former Chief Architect and Senior Director of Cardio Engineering at Life Fitness, IMPOWER HEALTH emerged from Miller's decades-long career at the intersection of biomechanics and treadmill engineering. In 2020, his collaboration with the Biomechanics Team at the University of Nebraska at Omaha and UNeTech unlocked a breakthrough in quantifying and tracking gait and mobility through treadmills, forming the basis for IMPOWER HEALTH's technology.

"Bringing on the right CEO at this stage is about preparing the company for growth," said Doug Miller, Founder & Chief Product Officer of IMPOWER HEALTH. "Trent brings the operational leadership and decisive discipline needed to translate our technology into real-world impact, while staying true to the vision that inspired our founding."

About Boomerang Ventures

Founded in 2019, Boomerang Ventures is a venture capital firm focused on early growth-stage connected health technology companies. Leveraging a combination studio and venture fund, Boomerang provides the collaborative direction, deep industry expertise, and continuum of support founders need to take their innovations from ideation to market. Boomerang believes that better patient care begins with identifying and solving the biggest challenges in healthcare. Boomerang Ventures is proudly and strategically based in Indianapolis, where the healthcare and entrepreneurial business climate is a thriving community ripe with opportunities. With a secure niche at the intersection of health technology, studio-fund synchronization, and the Midwest, Boomerang differentiates itself from the competition. Boomerang Ventures is Healthcare Innovation, Reimagined. For more information, visit boomerang.vc.

About IMPOWER HEALTH, Inc.

Founded in 2021 and headquartered in Omaha, Nebraska, IMPOWER HEALTH provides rehab clinicians and fitness trainers with the objective clinical data they need to proactively manage mobility health. The company's patented software transforms standard treadmills into real-time gait labs-capturing precise, clinically meaningful movement metrics without wearables or cameras. By making advanced gait and mobility analytics as accessible as heart rate and blood pressure, IMPOWER HEALTH accelerates recovery, optimizes performance, and helps preserve independence. For more information, visit goimpower.com.

Media Contact:

Audra Wait, President
Wait & Co. (on behalf of Boomerang Ventures)
[email protected] | 615.504.8812

SOURCE: Boomerang Ventures



View the original press release on ACCESS Newswire

M.Delgado--TFWP